ResMed Analyst Ratings
BenzingaApr 27 01:54
Needham: Maintaining the ResMed (RMD.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $224.00 to $236.00.
Zhitong FinanceApr 26 18:30
ResMed Analyst Ratings
BenzingaApr 26 18:21
Needham Maintains Buy on ResMed, Raises Price Target to $236
BenzingaApr 26 18:24
Analysts Are Bullish on Top Healthcare Stocks: Accolade (ACCD), Resmed (RMD)
TipRanksApr 26 18:11
RBC Adjusts Price Target on ResMed to $200 From $187
MT NewswiresApr 26 18:16
Analysts' Opinions Are Mixed on These Healthcare Stocks: Integer Holdings (ITGR), Resmed (RMD) and PTC Therapeutics (PTCT)
TipRanksApr 26 18:03
KeyBanc Keeps Their Buy Rating on Resmed (RMD)
TipRanksApr 26 14:31
Analysts Offer Insights on Healthcare Companies: Novartis AG (Six Swiss: CH:NOVN), Carl Zeiss Meditec (GB:0DHC) and Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (AU:RMD)
TipRanksApr 17 17:06
Resmed Stock Poised for Growth: Buy Rating Affirmed Amid Revenue Upswing and Margin Expansion
TipRanksApr 17 17:10
Analysts Are Bullish on Top Healthcare Stocks: InMode (INMD), Resmed (RMD)
TipRanksApr 12 13:50
Analyst Upgrades Resmed Price Target to $224, Maintains Buy Rating Amidst Market Opportunities and OSA Trial Developments
TipRanksApr 1 17:35
ResMed Analyst Ratings
BenzingaApr 1 17:19
Needham Maintains Buy on ResMed, Raises Price Target to $224
BenzingaApr 1 17:22
Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Merck & Company (MRK)
TipRanksMar 28 12:20
ResMed Analyst Ratings
BenzingaMar 28 01:14
Mizuho Maintains Buy on ResMed, Maintains $215 Price Target
BenzingaMar 28 01:15
Morgan Stanley Adjusts Resmed's Price Target to AU$31.80 From AU$28.60, Keeps at Overweight
MT NewswiresMar 6 10:16
Evans & Partners Upgrades ResMed to Positive From Neutral, Price Target Is AU$31
MT NewswiresMar 4 16:13
ResMed Analyst Ratings
BenzingaFeb 6 20:08
No Data
No Data